Literature DB >> 28278712

Nonrandom occurrence of lymphoid cancer types in 140 families.

Samantha J Jones1,2, Jackson Voong3, Ruth Thomas1, Amy English1, Johanna Schuetz1, Graham W Slack4,5, Jinko Graham3, Joseph M Connors4, Angela Brooks-Wilson1,6.   

Abstract

We studied 140 families with two or more lymphoid cancers, including non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), chronic lymphocytic leukemia (CLL), and multiple myeloma (MM), for deviation from the population age of onset and lymphoid cancer co-occurrence patterns. Median familial NHL, HL, CLL and MM ages of onset are substantially earlier than comparable population data. NHL, HL and CLL (but not MM) also show earlier age of onset in later generations, known as anticipation. The co-occurrence of lymphoid cancers is significantly different from that expected based on population frequencies (p < .0001), and the pattern differs more in families with more affected members (p < .0001), suggesting specific lymphoid cancer combinations have a shared genetic basis. These families provide evidence for inherited factors that increase the risk of multiple lymphoid cancers. This study was approved by the BC Cancer Agency - University of British Columbia Clinical Research Ethics Board.

Entities:  

Keywords:  Familial lymphoma; anticipation; co-occurrence; genetic susceptibility

Mesh:

Year:  2017        PMID: 28278712     DOI: 10.1080/10428194.2017.1281412

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Bilateral breast implant associated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A case report.

Authors:  Patrick P Bletsis; Laura E Janssen; Otto Visser; Saskia R Offerman; Michiel A Tellier; Laurens Laterveer; Peter Houpt
Journal:  Int J Surg Case Rep       Date:  2020-05-29

2.  Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders.

Authors:  Viggo Jønsson; Haneef Awan; Neil Deaton Jones; Tom Børge Johannesen; Klaus Thøgersen; Bjarni Á Steig; Gudrid Andorsdottir; Geir Erland Tjønnfjord
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

3.  Datasets for a simulated family-based exome-sequencing study.

Authors:  Nirodha Epasinghege Dona; Jinko Graham
Journal:  Data Brief       Date:  2022-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.